The Graduate Certificate in Translational Biomedical Engineering enables students to lead the commercialization of innovative medical technology. This 15-credit graduate-level program prepares students for leadership roles in the medical technology industry. Core courses are taught by industry-leading experts, and complementary courses by world-class professors in biomedical engineering.
Who is the program best suited for?
This program is designed for recent graduates or encumbent industry members with a Bachelor of Engineering, Science, Economics, or Management degree. Applicants must have proven quantitative and analytical skills, and a desire to launch or grow a professional career in the medical technology industry.
Duration: Two terms (15 credits)
Available Start Dates: Fall and Winter semesters
Format: Full-Time or Part-Time, On-Campus
Pre-requisites:
Undergraduate Degree | Required Course(s) |
All students | PHGY 209 Mammalian Physiology 1 and PHGY 210 Mammalian Physiology 2, or the equivalent of both courses |
Engineering degree | One Life Science course (3 credits). More Details |
Non-Engineering degree |
Four quantitative courses (12 credits), of which two courses must be in Math, AND, Four natural science courses (12 credits), of which one course must be in Life Science. More Details |
Level of Pre-Degree Work Experience: None required
Possible Career Outcomes: R&D Manager, Clinical Trials Coordinator, Quality Assurance & Regulatory Affairs (QA/RA) Associate, Patent Agent

Cutting-edge reserch
McGill's Department of Biomedical Engineering is internationally recognized for its excellence in research and education, while McGill University consistently ranks among the top 40 universities in the world (QS World University Rankings 2019).
Students in this program learn with experienced industry experts and world-renowned professors in biomedical engineering.

Essential industry knowledge
Students learn with industry experts to cover three core topics in Translational BME:
1) Clinical Trials,
2) Intellectual Property, and,
3) Quality Management & Regulatory Affairs.
The program integrates core translational courses with in-depth exposure to research areas in biomedical engineering.
Translational News
Mutation leading to biological changes may play role in cancer
Published: 10 Sep 2020